GPR27 and diabetes mellitus: Here, we used such a system to identify a novel GPCR regulator of both insulin secretion and insulin promoter activity – Gpr27. Based on its islet expression and its positive effects on the insulin promoter and insulin secretion, we suggest that Gpr27 may be a novel target for diabetes therapies.